Facebook
X
LinkedIn
ForwardDate & Time of Session - 6/3/26 - from 2:30 - 3:30PM
Overview
In 2025, the Infectious Diseases Society of America (IDSA) released updated definitions and evidence-based recommendations for the management of complicated urinary tract infections (cUTIs). As medication experts and key members of the healthcare team, pharmacists play a critical role in optimizing antimicrobial therapy and advancing antimicrobial stewardship efforts. Staying current with evolving guideline recommendations enables pharmacists to improve patient outcomes, minimize resistance, reduce treatment failures, and promote safer, more effective antibiotic use across care settings. This presentation will review key updates from the revised guidelines, examine the evidence supporting these recommendations, and provide clinical opportunities to apply the recommendations in patient cases.
Objectives
Upon completion of this activity, the participant will be able to:
1.Define complicated urinary tract infections (cUTIs)
2.Differentiate complicated from uncomplicated UTIs based on key clinical features and risk factors
3.Apply the IDSA cUTI guidelines recommendations to de-escalate patients on treatment for cUTI
4.Describe current guideline-recommended treatment durations for cUTIs, emphasizing evidence supporting 7 days of therapy
Target Audience
Pharmacists, physicians, nurses, fellows and residents
Speaker
Miranda Arzate, PharmD
PGY2 Infectious Diseases Pharmacy Resident
Norton Healthcare
Louisville, Kentucky
- 1.00 ACPE
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number: JA0000312-9999-25-051-L01-P
- 1.00 AMA PRA Category 1 Credit™
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This Live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC (UK Healthcare CECentral)
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour(s).
- 1.00 IPCE
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.
- 1.00 ParticipationUK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.